Stock listing

Gsk Plc

Selected listing: A3DMHS · LSX · EUR · DE

Gsk Plc (LS Exchange: A3DMHS), Health Technology. Latest release Oct 6, 2026: Admission to Trading. Latest call replay: GSK plc (GSK) Q2 2026 Earnings Call.

A3DMHS:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A3DMHS
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

Latest news from Gsk Plc

Admission to Trading

October 6, 2026

Total Voting Rights

October 1, 2026

GSK : to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from Chimagen Biosciences

September 15, 2026

Jideytro positive data for ROS1-positive NSCLC

September 14, 2026

GSK : presents positive registrational data to potentially expand Jideytro (zidesamtinib) to first-line ROS1-positive non-small cell lung cancer

September 13, 2026

All Gsk Plc news →

Events

Replays

GSK plc (GSK) Q2 2026 Earnings Call
Tue, Jul 28, 2026 · 07:00 AM ET
Watch
GSK plc (GSK) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 07:00 AM ET
Watch
GSK plc (GSK) Q4 2025 Earnings Call
Wed, Feb 04, 2026 · 06:00 AM ET
Watch

Research Gsk Plc

Gsk Plc company profile

View the public company page for Gsk Plc on 6ix.

Gsk Plc news

Read company news and market updates connected to Gsk Plc.

Gsk Plc investor events

Find investor webinars, events, and replay context for Gsk Plc.